On February 28, 2023, the company received $1,700,000 in its first tranche. The transaction included participation from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd. and Huons Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33,850 KRW | -0.15% | -3.15% | -11.85% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
64,200 KRW | -1.53% | -0.93% | 414M | ||
33,850 KRW | -0.15% | -3.15% | 294M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.85% | 294M | |
+29.96% | 684B | |
+30.34% | 568B | |
-3.90% | 361B | |
+18.29% | 329B | |
+4.13% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+6.84% | 166B |
- Stock Market
- Equities
- A243070 Stock
- News Huons Co., Ltd.
- GenEdit Inc. amended terms of the transaction